Cardiovascular Disease in Type 1 Diabetes

Research output: Chapter in Book/Report/Conference proceedingChapter (peer-reviewed)peer-review

Standard

Cardiovascular Disease in Type 1 Diabetes. / Narendran, Parth.

Cardiovascular Endocrinology and Metabolism. ed. / John Petrie. 2019.

Research output: Chapter in Book/Report/Conference proceedingChapter (peer-reviewed)peer-review

Harvard

Narendran, P 2019, Cardiovascular Disease in Type 1 Diabetes. in J Petrie (ed.), Cardiovascular Endocrinology and Metabolism.

APA

Narendran, P. (2019). Cardiovascular Disease in Type 1 Diabetes. In J. Petrie (Ed.), Cardiovascular Endocrinology and Metabolism

Vancouver

Narendran P. Cardiovascular Disease in Type 1 Diabetes. In Petrie J, editor, Cardiovascular Endocrinology and Metabolism. 2019

Author

Narendran, Parth. / Cardiovascular Disease in Type 1 Diabetes. Cardiovascular Endocrinology and Metabolism. editor / John Petrie. 2019.

Bibtex

@inbook{dfab1d038f1c4ec2b6a8bc3f036b78b4,
title = "Cardiovascular Disease in Type 1 Diabetes",
abstract = "Purpose of Review: Cardiovascular disease (CVD) is a well-recognised complication of diabetes. While the association of type 2 diabetes (T2D) with cardiovascular disease has been well described, the mechanisms, risk stratification and screening strategies of CVD in type 1 diabetes (T1D) are less understood. This review aims to evaluate recent literature and guidelines regarding CVD in T1D.Recent findings: At the cellular level, the early stage of CVD is characterised by endothelial dysfunction. Recent studies have shown that endothelial function is unaffected in younger T1D patients but there is a significant degree of endothelial dysfunction in the older T1D population compared to healthy age-matched controls, highlighting the importance of the endothelial dysfunction in T1D as a major age-dependent cardiovascular risk factor.T1D risk assessment tools have been developed similar to those seen in T2D. Foremost amongst these are the Danish Steno Type 1 risk engine, the Swedish T1D risk score, the Scottish T1D risk score and the QRISK risk calculator. The latter risk prediction tool is used for all patients but contains T1D as an independent risk variable and has the advantage of being derived from, and validated in, a large and diverse population. The latest version (QRISK3) is likely to be recommended for routine use in T1D patients in upcoming guidelines by the National Institute of Clinical Excellence (NICE).Summary: Mortality in adults with T1D is increasingly due to CVD. This is driven by hyperglycaemia-mediated oxidative stress and vascular inflammation, resulting in atherosclerosis and cardiac autonomic neuropathy. Coronary artery disease (CAD) is the most significant contributor to CVD and in T1D, has a propensity towards a more silent and severe form. Routine screening of coronary artery disease does not alter outcomes and is therefore not recommended; however, risk prediction tools are being developed to aid identification of high risk individuals for aggressive risk factor modification strategies.",
author = "Parth Narendran",
year = "2019",
language = "English",
editor = "John Petrie",
booktitle = "Cardiovascular Endocrinology and Metabolism",

}

RIS

TY - CHAP

T1 - Cardiovascular Disease in Type 1 Diabetes

AU - Narendran, Parth

PY - 2019

Y1 - 2019

N2 - Purpose of Review: Cardiovascular disease (CVD) is a well-recognised complication of diabetes. While the association of type 2 diabetes (T2D) with cardiovascular disease has been well described, the mechanisms, risk stratification and screening strategies of CVD in type 1 diabetes (T1D) are less understood. This review aims to evaluate recent literature and guidelines regarding CVD in T1D.Recent findings: At the cellular level, the early stage of CVD is characterised by endothelial dysfunction. Recent studies have shown that endothelial function is unaffected in younger T1D patients but there is a significant degree of endothelial dysfunction in the older T1D population compared to healthy age-matched controls, highlighting the importance of the endothelial dysfunction in T1D as a major age-dependent cardiovascular risk factor.T1D risk assessment tools have been developed similar to those seen in T2D. Foremost amongst these are the Danish Steno Type 1 risk engine, the Swedish T1D risk score, the Scottish T1D risk score and the QRISK risk calculator. The latter risk prediction tool is used for all patients but contains T1D as an independent risk variable and has the advantage of being derived from, and validated in, a large and diverse population. The latest version (QRISK3) is likely to be recommended for routine use in T1D patients in upcoming guidelines by the National Institute of Clinical Excellence (NICE).Summary: Mortality in adults with T1D is increasingly due to CVD. This is driven by hyperglycaemia-mediated oxidative stress and vascular inflammation, resulting in atherosclerosis and cardiac autonomic neuropathy. Coronary artery disease (CAD) is the most significant contributor to CVD and in T1D, has a propensity towards a more silent and severe form. Routine screening of coronary artery disease does not alter outcomes and is therefore not recommended; however, risk prediction tools are being developed to aid identification of high risk individuals for aggressive risk factor modification strategies.

AB - Purpose of Review: Cardiovascular disease (CVD) is a well-recognised complication of diabetes. While the association of type 2 diabetes (T2D) with cardiovascular disease has been well described, the mechanisms, risk stratification and screening strategies of CVD in type 1 diabetes (T1D) are less understood. This review aims to evaluate recent literature and guidelines regarding CVD in T1D.Recent findings: At the cellular level, the early stage of CVD is characterised by endothelial dysfunction. Recent studies have shown that endothelial function is unaffected in younger T1D patients but there is a significant degree of endothelial dysfunction in the older T1D population compared to healthy age-matched controls, highlighting the importance of the endothelial dysfunction in T1D as a major age-dependent cardiovascular risk factor.T1D risk assessment tools have been developed similar to those seen in T2D. Foremost amongst these are the Danish Steno Type 1 risk engine, the Swedish T1D risk score, the Scottish T1D risk score and the QRISK risk calculator. The latter risk prediction tool is used for all patients but contains T1D as an independent risk variable and has the advantage of being derived from, and validated in, a large and diverse population. The latest version (QRISK3) is likely to be recommended for routine use in T1D patients in upcoming guidelines by the National Institute of Clinical Excellence (NICE).Summary: Mortality in adults with T1D is increasingly due to CVD. This is driven by hyperglycaemia-mediated oxidative stress and vascular inflammation, resulting in atherosclerosis and cardiac autonomic neuropathy. Coronary artery disease (CAD) is the most significant contributor to CVD and in T1D, has a propensity towards a more silent and severe form. Routine screening of coronary artery disease does not alter outcomes and is therefore not recommended; however, risk prediction tools are being developed to aid identification of high risk individuals for aggressive risk factor modification strategies.

M3 - Chapter (peer-reviewed)

BT - Cardiovascular Endocrinology and Metabolism

A2 - Petrie, John

ER -